WallStreetZenWallStreetZen

NASDAQ: ARVN
Arvinas Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ARVN

Based on 7 analysts offering 12 month price targets for Arvinas Inc

Min Forecast
$11.00+45.12%
Avg Forecast
$18.57+145%
Max Forecast
$24.00+216.62%

Should I buy or sell ARVN stock?

Based on 7 analysts offering ratings for Arvinas Inc.

Strong Buy
Strong Buy
5 analysts 71.43%
Buy
1 analysts 14.29%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ARVN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ARVN as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ARVN stock forecasts and price targets.

ARVN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-03
lockedlocked$00.00+00.00%2026-05-13Find Out Why
lockedlocked$00.00+00.00%2026-05-13Find Out Why
lockedlocked$00.00+00.00%2026-05-04Find Out Why
lockedlocked$00.00+00.00%2026-02-25
Evercore ISI Group
Bottom 9%
9
BuyMaintains$19.00+150.66%2026-02-25
Wedbush
Top 12%
89
HoldMaintains$11.00+45.12%2026-02-25

1 of 1

Forecast return on equity

Is ARVN forecast to generate an efficient return?

Company
-39.21%
Industry
95.51%
Market
175.55%
ARVN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARVN forecast to generate an efficient return on assets?

Company
-23.42%
Industry
28.06%
ARVN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARVN earnings per share forecast

What is ARVN's earnings per share in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
-$3.07
Avg 2 year Forecast
-$3.39
Avg 3 year Forecast
-$3.22

ARVN revenue forecast

What is ARVN's revenue in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$115.1M+28.75%
Avg 2 year Forecast
$73.8M-17.48%
Avg 3 year Forecast
$88.3M-1.25%
ARVN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARVN revenue growth forecast

How is ARVN forecast to perform vs Biotechnology companies and vs the US market?

Company
-5.16%
Industry
33.61%
Market
13.79%
ARVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARVN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARVN$7.58$18.57+145.00%Strong Buy
KYTX$8.06$29.00+260.02%Strong Buy
CABA$3.01$15.75+423.26%Strong Buy
CBIO$17.92$28.50+59.04%Strong Buy
PROK$1.64$12.00+631.71%Buy
View Top Biotech Stocks

Arvinas Stock Forecast FAQ

Is Arvinas Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: ARVN) stock is to Strong Buy ARVN stock.

Out of 7 analysts, 5 (71.43%) are recommending ARVN as a Strong Buy, 1 (14.29%) are recommending ARVN as a Buy, 1 (14.29%) are recommending ARVN as a Hold, 0 (0%) are recommending ARVN as a Sell, and 0 (0%) are recommending ARVN as a Strong Sell.

If you're new to stock investing, here's how to buy Arvinas stock.

What is ARVN's earnings growth forecast for 2026-2028?

(NASDAQ: ARVN) Arvinas's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.65%.

Arvinas's earnings in 2026 is -$221,300,000.On average, 20 Wall Street analysts forecast ARVN's earnings for 2026 to be -$197,763,924, with the lowest ARVN earnings forecast at -$272,524,636, and the highest ARVN earnings forecast at -$123,977,482. On average, 19 Wall Street analysts forecast ARVN's earnings for 2027 to be -$218,804,287, with the lowest ARVN earnings forecast at -$304,140,023, and the highest ARVN earnings forecast at -$141,591,769.

In 2028, ARVN is forecast to generate -$208,022,794 in earnings, with the lowest earnings forecast at -$269,995,405 and the highest earnings forecast at -$109,073,085.

What is ARVN's revenue growth forecast for 2026-2028?

(NASDAQ: ARVN) Arvinas's forecast annual revenue growth rate of -5.16% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.

Arvinas's revenue in 2026 is $89,400,000.On average, 20 Wall Street analysts forecast ARVN's revenue for 2026 to be $7,426,389,890, with the lowest ARVN revenue forecast at $1,049,630,849, and the highest ARVN revenue forecast at $13,077,801,623. On average, 19 Wall Street analysts forecast ARVN's revenue for 2027 to be $4,759,857,819, with the lowest ARVN revenue forecast at $1,568,574,845, and the highest ARVN revenue forecast at $8,516,152,924.

In 2028, ARVN is forecast to generate $5,695,995,881 in revenue, with the lowest revenue forecast at $2,141,974,731 and the highest revenue forecast at $13,366,856,590.

What is ARVN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ARVN) forecast ROA is -23.42%, which is lower than the forecast US Biotechnology industry average of 28.06%.

What is ARVN's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ARVN price target, the average ARVN price target is $18.57, with the highest ARVN stock price forecast at $24.00 and the lowest ARVN stock price forecast at $11.00.

On average, Wall Street analysts predict that Arvinas's share price could reach $18.57 by Jun 3, 2027. The average Arvinas stock price prediction forecasts a potential upside of 145% from the current ARVN share price of $7.58.

What is ARVN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ARVN) Arvinas's current Earnings Per Share (EPS) is -$3.18. On average, analysts forecast that ARVN's EPS will be -$3.07 for 2026, with the lowest EPS forecast at -$4.22, and the highest EPS forecast at -$1.92. On average, analysts forecast that ARVN's EPS will be -$3.39 for 2027, with the lowest EPS forecast at -$4.71, and the highest EPS forecast at -$2.19. In 2028, ARVN's EPS is forecast to hit -$3.22 (min: -$4.18, max: -$1.69).

What is ARVN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ARVN) forecast ROE is -39.21%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.